Intervention Review

Treatment for amphetamine withdrawal

  1. Steven J Shoptaw1,*,
  2. Uyen Kao1,
  3. Keith Heinzerling1,
  4. Walter Ling2

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 15 APR 2009

DOI: 10.1002/14651858.CD003021.pub2

How to Cite

Shoptaw SJ, Kao U, Heinzerling K, Ling W. Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD003021. DOI: 10.1002/14651858.CD003021.pub2.

Author Information

  1. 1

    University of California, Department of Family Medicine, Los Angeles, CA, USA

  2. 2

    David Geffen School of Medicine at UCLA, Integrated Substance abuse Programs, Department of Psychiatry and Biobehavioral Sciences, Los Angeles, California, USA

*Steven J Shoptaw, Department of Family Medicine, University of California, 10880 Wilshire Boulevard, Suite 540, Los Angeles, CA, 90024, USA.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 15 APR 2009


Cited in:


This article has been cited by:

  1. 1
    J. Quinlan, F. Cox, Akutschmerztherapie bei Patienten mit Substanzabhängigkeitssyndrom, Der Schmerz, 2018,


  2. 2
    Ying Li, Jie Gao, Shu He, Yan Zhang, Qiwei Wang, An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments, Molecular Neurobiology, 2017, 54, 9, 6655


  3. 3
    Corey Hassell, Kirsten Wilkins, Louis A. Trevisan, Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions, Current Treatment Options in Psychiatry, 2017, 4, 1, 102


  4. 4
    Tomislav Majić, Thorsten Kienast, Andreas Heinz, Michael Soyka, Psychiatrie, Psychosomatik, Psychotherapie, 2017,


  5. 5
    Shayan Amiri, Sakineh Alijanpour, Fatemeh Tirgar, Arya Haj-Mirzaian, Hossein Amini-Khoei, Maryam Rahimi-Balaei, Mojgan Rastegar, Marzieh Ghaderi, Mahmoud Ghazi-Khansari, Mohammad-Reza Zarrindast, NMDA receptors are involved in the antidepressant-like effects of capsaicin following amphetamine withdrawal in male mice, Neuroscience, 2016, 329, 122


  6. 6
    Tomislav Majić, Thorsten Kienast, Andreas Heinz, Michael Soyka, Psychiatrie, Psychosomatik, Psychotherapie, 2016,


  7. 7
    Yi Che, Yong-Hua Cui, Hua Tan, Ana C. Andreazza, L. Trevor Young, Jun-Feng Wang, Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain, Psychopharmacology, 2013, 227, 4, 605


  8. 8
    AR Lingford-Hughes, S Welch, L Peters, DJ Nutt, BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP, Journal of Psychopharmacology, 2012, 26, 7, 899


  9. 9
    Michael J. Mancino, Brooks W. Gentry, Zachary Feldman, John Mendelson, Alison Oliveto, Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study, The American Journal of Drug and Alcohol Abuse, 2011, 37, 2, 131


  10. 10
    Clara Pérez-Mañá, Xavier Castells, Marta Torrens, Dolors Capellà, Magi Farre, Efficacy of psychostimulant drugs for amphetamine abuse or dependence, The Cochrane Library,